View this email in your browser
Join our first two webinars of 2022!
We hope you had a happy and restful holiday season and wish you a prosperous 2022! This month, GARDP will be hosting two REVIVE webinars. On 19 January, Valeria Gigante, Bala Subramanian and Daniela Zinzi will discuss the value of target candidate profiles and target product profiles for new antimicrobials. This will be followed by a second webinar on 26 January with presentations and a panel discussion on the technologies and strategies to overcome the challenges of sexually transmitted infections. 

If you have not done so already, please register and join us for this year's virtual Antimicrobial Chemotherapy Conference. There will be a keynote presentation from Professor Ramanan Laxminarayan as well as panel discussions and presentations on early drug discovery and clinical development. 

As always, you can read our Antimicrobial Viewpoints, watch recordings of previous webinars and conferences as well as discover new terms in the Antimicrobial Encyclopaedia on the REVIVE website

Kind regards,
the REVIVE team
REVIVE webinars
Join our panellists as they discuss the challenges of STIs and the strategies and technologies to overcome them.
Antimicrobial Chemotherapy Conference
There is still time to register for this year's Antimicrobial Chemotherapy Conference. Visit the website where you can find the programme and registration link.
Antimicrobial Encyclopaedia
Find out the meaning of terms such as AUC/MIC, plasmid and transduction in the Antimicrobial Encyclopaedia. You can also watch new videos from Angela Huttner, Martha Clokie and Stephan Harbarth. 
Other news
  • Watch the recording of the AMR Bootcamp that took place at the 2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance in December. 
  • In December, GARDP hosted a high-level panel discussion at the UNITE Global Summit focused on G7 leadership in accelerating the response to AMR. Watch the recording here
Copyright © 2022 Global Antibiotic Research and Development Partnership (GARDP), All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp